Snowball logo
logo
6846

Greenyn Biotechnology Co., Ltd

6846 โ€ข TWO
NT$58.00-NT$1.60ย  (2.68%)
Estimate
P/E
14.9
EPS
3.9
Beta
0.15
Growth
Revenue, YoY
-14.89%
Net income, YoY
-29.9%
FCF, YoY
70.19%
Dividends
Dividend yield
6.8%
Annual payout
NT$3.94
Next ex. div date
June 25, 27
Payout
66.76%
Dividend growth streak
2 y
Div.rating
About the company
Ticker
6846
ISIN
Country
Taiwan
Sector (GICS)
Other
Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for youth and beauty series, digestive health series, brain health series, body regulation series, throat moistening series, hair care series, clear eye series, colorful lifestyle series, joint health series, nutritional supplement series, energy supplement series, immune modulation series, low burden series, sleep aid series, body curve series, circulation series, man power series, women's intimate health series, and mature woman series. In addition, the company offers customization, ODM, dosage, and application services. Greenyn Biotechnology Co., Ltd was founded in 2012 and is based in Taichung, Taiwan.

Frequently asked questions

What sector does Greenyn Biotechnology Co., Ltd (6846) operate in?

Greenyn Biotechnology Co., Ltd belongs to the Other sector and operates in the Biotechnology industry.

What is Greenyn Biotechnology Co., Ltd (6846) current stock price?

As of the latest data, Greenyn Biotechnology Co., Ltd stock price is NT$58.00, with a previous close of NT$59.60. Greenyn Biotechnology Co., Ltd lost -NT$1.60 in the last trading session, representing a -2.68% loss.

What is Greenyn Biotechnology Co., Ltd (6846) current market capitalization?

Greenyn Biotechnology Co., Ltd market cap is approximately 1.57 billion.

What is Greenyn Biotechnology Co., Ltd (6846) Earnings Per Share (EPS)?

The trailing EPS is NT$3.90.

What is Greenyn Biotechnology Co., Ltd (6846) Price-to-Earnings (P/E) ratio?

Greenyn Biotechnology Co., Ltd current P/E ratio is 14.87.

Does Greenyn Biotechnology Co., Ltd (6846) pay dividends?

Yes. Greenyn Biotechnology Co., Ltd pays annual dividends with an annualized yield of 6.8% and an estimated annual payout of NT$3.94 per share.

When is the next ex-dividend date for Greenyn Biotechnology Co., Ltd (6846)?

The next ex-dividend date is scheduled for June 25, 2027.

What is Greenyn Biotechnology Co., Ltd (6846) beta (volatility) score?

Greenyn Biotechnology Co., Ltd has a beta of 0.150, indicating lower volatility than the overall market.